CA2376023A1 - Therapeutic agents - Google Patents
Therapeutic agents Download PDFInfo
- Publication number
- CA2376023A1 CA2376023A1 CA002376023A CA2376023A CA2376023A1 CA 2376023 A1 CA2376023 A1 CA 2376023A1 CA 002376023 A CA002376023 A CA 002376023A CA 2376023 A CA2376023 A CA 2376023A CA 2376023 A1 CA2376023 A1 CA 2376023A1
- Authority
- CA
- Canada
- Prior art keywords
- tetrahydro
- benzothiazepine
- alkyl
- carbon atoms
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Addiction (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9914745.6 | 1999-06-24 | ||
GBGB9914745.6A GB9914745D0 (en) | 1999-06-24 | 1999-06-24 | Therapeutic agents |
PCT/EP2000/005541 WO2001000185A2 (en) | 1999-06-24 | 2000-06-16 | 1,4-denzothiazepines to treat obesity related disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2376023A1 true CA2376023A1 (en) | 2001-01-04 |
Family
ID=10855956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002376023A Abandoned CA2376023A1 (en) | 1999-06-24 | 2000-06-16 | Therapeutic agents |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1218010A2 (de) |
JP (1) | JP2003513008A (de) |
AU (1) | AU5973600A (de) |
CA (1) | CA2376023A1 (de) |
GB (1) | GB9914745D0 (de) |
MX (1) | MXPA01013420A (de) |
WO (1) | WO2001000185A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8710045B2 (en) | 2004-01-22 | 2014-04-29 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the ryanodine receptors |
US7704990B2 (en) * | 2005-08-25 | 2010-04-27 | The Trustees Of Columbia University In The City Of New York | Agents for preventing and treating disorders involving modulation of the RyR receptors |
JP5497429B2 (ja) * | 2007-03-07 | 2014-05-21 | 武田薬品工業株式会社 | ベンゾオキサゼピン誘導体およびその用途 |
JP2012508692A (ja) | 2008-11-12 | 2012-04-12 | シェーリング コーポレイション | 脂肪酸結合タンパク質(fabp)の阻害薬 |
WO2013064231A1 (en) | 2011-10-31 | 2013-05-10 | Phenex Pharmaceuticals Ag | SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3) |
EP2708535A1 (de) | 2012-05-11 | 2014-03-19 | Les Laboratoires Servier | Mittel zur Behandlung von Erkrankungen durch Modulation von Ryanodin-Rezeptoren |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3361760A (en) * | 1963-03-21 | 1968-01-02 | Squibb & Sons Inc | Benzothiazepines |
US3794639A (en) * | 1966-03-10 | 1974-02-26 | Squibb & Sons Inc | Benzoxazepines and benzothiazepines |
JP2871811B2 (ja) * | 1990-02-28 | 1999-03-17 | サントリー株式会社 | 縮合7員環系化合物 |
GB9203347D0 (en) * | 1992-02-17 | 1992-04-01 | Wellcome Found | Hypolipidaemic compounds |
JP3093419B2 (ja) * | 1992-03-30 | 2000-10-03 | 麒麟麦酒株式会社 | 1,4‐ベンゾチアゼピン誘導体 |
ES2113081T3 (es) * | 1992-11-09 | 1998-04-16 | Knoll Ag | 1,4-benzotiazepinas utiles como agentes neurologicos. |
US5610153A (en) * | 1992-12-11 | 1997-03-11 | Ciba-Geigy Corporation | Benzazepinone derivatives |
IL108633A (en) * | 1993-02-15 | 1998-07-15 | Wellcome Found | History of Benzothiazepine Hypolipidemic Preparation and Pharmaceutical Preparations Containing Them |
IL108634A0 (en) * | 1993-02-15 | 1994-05-30 | Wellcome Found | Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them |
ZA956647B (en) * | 1994-08-10 | 1997-02-10 | Wellcome Found | Hypolipidaemic compounds. |
DE69815180T2 (de) * | 1997-03-14 | 2004-04-29 | Aventis Pharma Deutschland Gmbh | Hypolipidemische 1,4-Benzothiazepin-1,1-dioxide |
CN1213036C (zh) * | 1997-08-22 | 2005-08-03 | 科研制药株式会社 | 新的酰胺类衍生物 |
-
1999
- 1999-06-24 GB GBGB9914745.6A patent/GB9914745D0/en not_active Ceased
-
2000
- 2000-06-16 CA CA002376023A patent/CA2376023A1/en not_active Abandoned
- 2000-06-16 MX MXPA01013420A patent/MXPA01013420A/es unknown
- 2000-06-16 EP EP00945759A patent/EP1218010A2/de not_active Withdrawn
- 2000-06-16 WO PCT/EP2000/005541 patent/WO2001000185A2/en not_active Application Discontinuation
- 2000-06-16 JP JP2001505895A patent/JP2003513008A/ja not_active Withdrawn
- 2000-06-16 AU AU59736/00A patent/AU5973600A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
GB9914745D0 (en) | 1999-08-25 |
MXPA01013420A (es) | 2002-07-22 |
WO2001000185A2 (en) | 2001-01-04 |
JP2003513008A (ja) | 2003-04-08 |
EP1218010A2 (de) | 2002-07-03 |
AU5973600A (en) | 2001-01-31 |
WO2001000185A3 (en) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5942549A (en) | Improving glucose tolerance | |
EP0236684B1 (de) | Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit | |
US6174925B1 (en) | Use of sibutramine analogues to prevent the development of diabetes | |
CA2402609A1 (en) | Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates for the preparation of the derivatives | |
ES2199374T3 (es) | Derivados de 1-(1-(4-clorofenil)ciclobutil)-3-metilbutilamina para reducir el nivel de acido urico en seres humanos. | |
EP1039900B1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
JPH0637395B2 (ja) | ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤 | |
CA2376023A1 (en) | Therapeutic agents | |
JP2549480B2 (ja) | 排尿障害改善剤 | |
CA2376886A1 (en) | Therapeutic agents | |
WO1995028933A1 (en) | Use of arylpiperazine derivatives for the treatment of parkinson's disease and psychosis | |
WO1997023477A1 (en) | Dibenzothiepin derivatives and pharmaceutical compositions | |
EP0946181B1 (de) | Verwendung von 2-(2-morpholinophenyl)guanidinderivate zur behandlung von diabetes-komplikationen | |
AU2730800A (en) | Method to aid smoking cessation | |
CA2501093A1 (en) | Combinations of benzodithiazoles and cox-2 inhibitors for the treatment of pain | |
CZ9901055A3 (cs) | Léčivo a farmaceutická kompozice pro snižování hladiny kyseliny močové | |
JP2001213783A (ja) | 動物用治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |